Literature DB >> 31710694

Safety and effectiveness of thalidomide and hydroxyurea combination in β-thalassaemia intermedia and major: a retrospective pilot study.

Sandip Shah1, Radhika Sheth1, Kamlesh Shah2, Kinnari Patel2.   

Abstract

Entities:  

Year:  2019        PMID： 31710694     DOI： 10.1111/bjh.16272

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Alternative Strategies in Thalassemia: Focus on Thalidomide.

Authors:  R Naithani; P Jeyaraman; M Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2020-05-05       Impact factor: 0.900

2.  Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.

Authors:  Dinesh Bhurani; Jyotsna Kapoor; Neha Yadav; Vishvdeep Khushoo; Narendra Agrawal; Rayaz Ahmed; Jatinder Singh Arora; Pallavi Mehta
Journal:  Ann Hematol       Date:  2021-04-03       Impact factor: 3.673

Review 3.  Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.

Authors:  George J Kontoghiorghes; Christina N Kontoghiorghe
Journal:  Cells       Date:  2020-06-12       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.